{"id":"e-hdfl-ep-te-n-hdfl-np-t-hdfl-tp","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Further research is needed to understand the exact mechanisms of these drugs.","oneSentence":"E-HDFL, EP, TE, N-HDFL, NP, T-HDFL, TP are investigational drugs with unknown mechanisms of action.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:10:30.137Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT00776724","phase":"PHASE3","title":"Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2008-05-29","conditions":"Breast Cancer, Chemotherapy","enrollment":166}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP","genericName":"E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP","companyName":"National Taiwan University Hospital","companyId":"national-taiwan-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}